Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Prediman K. Shah

Prediman K. Shah

individual
Ecosystem influencer

About

Prediman K. Shah is a Los Angeles-based cardiologist, cardiovascular researcher, and academic focused on atherosclerosis, inflammation, and novel heart-disease therapies. He serves at Cedars-Sinai as Chair, Clinical Cardiology and leads the Oppenheimer Atherosclerosis Research Center/Shah Lab; UCLA lists him as Professor-in-Residence in Medicine. Public company and biotech materials also place him in scientific advisory and board roles at Abcentra and Cyclarity Therapeutics.

Areas of interest

cardiologyclinical cardiologyatherosclerosiscardiovascular diseasepreventive cardiologylipid biologyinflammationimmunotherapygene-based therapiesobesity-metabolic syndromebiotech